Schwannoma

Title	Average Rating
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.	80.00%
Primary malignant schwannoma of the cervical plexus with melanocytic differentiation.	70.00%
The efficacy of corticosteroids in restoring hearing in patients undergoing conservative management of acoustic neuromas.'	70.00%
Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.	70.00%
Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review.	70.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary stu	60.00%
Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase path--	60.00%
Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidine.	60.00%
Primary melanocytic tumor of the cerebellopontine angle mimicking a vestibular schwannoma: case report.	60.00%
Propolis Extract (Bio 30) Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice	55.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary	50.00%
Management of the patient and family with neurofibromatosis 2: a consensus conference statement.	30.00%

Languages